scholarly journals Loss of Chromosome 13q

2020 ◽  
Author(s):  
Keyword(s):  
Chromosome 13Q

scholarly journals Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis

1998 ◽  
Vol 34 (13) ◽  
pp. 2076-2081 ◽  
Author(s):  
G Eiriksdottir ◽  
G Johannesdottir ◽  
S Ingvarsson ◽  
I.B Björnsdottir ◽  
J.G Jonasson ◽  
...  
Keyword(s):  
Loss Of Heterozygosity ◽  
Poor Prognosis ◽  
Tumour Progression ◽  
Breast Tumour ◽  
Chromosome 13Q

scholarly journals Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q

2003 ◽  
Vol 100 (5) ◽  
pp. 2550-2555 ◽  
Author(s):  
S. P. Hamilton ◽  
A. J. Fyer ◽  
M. Durner ◽  
G. A. Heiman ◽  
A. Baisre de Leon ◽  
...  
Keyword(s):  
Panic Disorder ◽  
Genetic Evidence ◽  
Chromosome 13Q

scholarly journals Chromosome 13q deletion syndrome involving 13q31-qter: A case report

2017 ◽  
Vol 15 (6) ◽  
pp. 3658-3664 ◽  
Author(s):  
Yue-Ping Wang ◽  
Da-Jia Wang ◽  
Zhi-Bin Niu ◽  
Wan-Ting Cui
Keyword(s):  
Case Report ◽  
Deletion Syndrome ◽  
Chromosome 13Q ◽  
13Q Deletion

Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity

2005 ◽  
Author(s):  
Wen-Hui Weng ◽  
Mikael Lerner ◽  
Dan Grandér ◽  
Jan Åhlén ◽  
Andrea Villablanca ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Abdominal Cavity ◽  
Soft Tissue Sarcomas ◽  
Chromosome 13Q

Factor VII and factor X deficiency in a child with a chromosome 13q duplication and deletion

Haemophilia ◽  
2017 ◽  
Author(s):  
K. Hutchins ◽  
M. Rajpurkar ◽  
D. W. Stockton ◽  
M. U. Callaghan
Keyword(s):  
Factor Vii ◽  
Factor X ◽  
Factor X Deficiency ◽  
Chromosome 13Q

scholarly journals Increased risk of suicide in schizophrenia patients with linkage to chromosome 13q

2017 ◽  
Vol 251 ◽  
pp. 34-35 ◽  
Author(s):  
P.J. Malherbe ◽  
M. Karayiorgou ◽  
R. Ehlers ◽  
J.L. Roos
Keyword(s):  
Increased Risk ◽  
Chromosome 13Q

Molecular Classification of Multiple Myeloma: A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations

2005 ◽  
Vol 23 (29) ◽  
pp. 7296-7306 ◽  
Author(s):  
Luca Agnelli ◽  
Silvio Bicciato ◽  
Michela Mattioli ◽  
Sonia Fabris ◽  
Daniela Intini ◽  
...  
Keyword(s):  
Gene Expression ◽  
Multiple Myeloma ◽  
Expression Profiles ◽  
Quantitative Polymerase Chain Reaction ◽  
Gene Expression Pattern ◽  
Marker Genes ◽  
Published Data ◽  
Cyclin D ◽  
Chromosome 13Q ◽  
13Q Deletion

Purpose The deregulation of CCND1, CCND2 and CCND3 genes represents a common event in multiple myeloma (MM). A recently proposed classification grouped MM patients into five classes on the basis of their cyclin D expression profiles and the presence of the main translocations involving the immunoglobulin heavy chain locus (IGH) at 14q32. In this study, we provide a molecular characterization of the identified translocations/cyclins (TC) groups. Materials and Methods The gene expression profiles of purified plasma cells from 50 MM cases were used to stratify the samples into the five TC classes and identify their transcriptional fingerprints. The cyclin D expression data were validated by means of real-time quantitative polymerase chain reaction analysis; fluorescence in situ hybridization was used to investigate the cyclin D loci arrangements, and to detect the main IGH translocations and the chromosome 13q deletion. Results Class-prediction analysis identified 112 probe sets as characterizing the TC1, TC2, TC4 and TC5 groups, whereas the TC3 samples showed heterogeneous phenotypes and no marker genes. The TC2 group, which showed extra copies of the CCND1 locus and no IGH translocations or the chromosome 13q deletion, was characterized by the overexpression of genes involved in protein biosynthesis at the translational level. A meta-analysis of published data sets validated the identified gene expression signatures. Conclusion Our data contribute to the understanding of the molecular and biologic features of distinct MM subtypes. The identification of a distinctive gene expression pattern in TC2 patients may improve risk stratification and indicate novel therapeutic targets.

Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q

1995 ◽  
Vol 10 (3) ◽  
pp. 354-356 ◽  
Author(s):  
Hans Eiberg ◽  
Ida Berendt ◽  
Jan Mohr
Keyword(s):  
Nocturnal Enuresis ◽  
Chromosome 13Q

scholarly journals Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

Leukemia ◽  
2000 ◽  
Vol 14 (11) ◽  
pp. 1975-1979 ◽  
Author(s):  
R Königsberg ◽  
J Ackermann ◽  
H Kaufmann ◽  
N Zojer ◽  
E Urbauer ◽  
...  
Keyword(s):  
Monoclonal Gammopathy ◽  
Chromosome 13Q ◽  
Undetermined Significance
Sign in / Sign up

Export Citation Format

Share Document